Rindopepimut
Information
- Drug Name
- Rindopepimut
- Description
- Entry(CIViC)
- 1
CIViC
| Disease | Mutation | EL | ET | ED | CS | VO | TR | Pubmed | Links |
|---|---|---|---|---|---|---|---|---|---|
| glioblastoma | EGFR VIII EGFR VIII | B |
Predictive
|
Supports
|
Sensitivity/Response | Somatic | 3 | 25586468 | Detail |
Annotation
| Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
|---|---|---|---|---|---|---|
| In a Phase II clinical trial, patients with Gliobl... | EGFR | EGFR VIII EGFR VIII | Sensitivity | true | CIViC Evidence | detail |
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03068650 | No longer available | Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut | |||
| NCT01058850 | Terminated | Phase 1 | Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas | June 2011 | September 2013 |